GlassScriptPhysician profile
Samuel S Im
NPI 1790839496
$3,832.74
in general payments reported to CMS, 2019-2025
13 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2021: $38.80 · 2023: $3,131 · 2024: $257 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $630.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,044.94 | 2021-2024 | Davinci Xi |
| Glaxosmithkline, LLC. | $248.11 | 2023-2025 | Zejula, Jemperli |
| Stryker Corporation | $155.56 | 2025 | Stryker |
| Genentech USA, INC. | $84.01 | 2019 | |
| Baxter Healthcare | $75.44 | 2019-2023 | Floseal |
| Conmed Corporation | $64.95 | 2023 | Airseal |
| Medtronic, INC. | $26.87 | 2023 | Ligasure |
| Astrazeneca Pharmaceuticals LP | $24.65 | 2025 | Lynparza |
| Ethicon US, LLC | $24.05 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
| Merck Sharp & Dohme LLC | $23.85 | 2024 | Bridion |
| Karl Storz Endoscopy-America | $23.05 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.56 | 2025 | |
| Organon LLC | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Im listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.